Caribou Biosciences, Inc.CRBUNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank78
5Y CAGR+19.6%
Year-over-Year Change
Year-over-year operating cash flow growth rate
5Y CAGR
+19.6%/yr
Long-term compound
Percentile
P78
Within normal range
vs 5Y Ago
2.4x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 17.32% |
| Q3 2025 | 10.87% |
| Q2 2025 | 23.06% |
| Q1 2025 | -3.54% |
| Q4 2024 | -8.60% |
| Q3 2024 | 0.62% |
| Q2 2024 | 11.66% |
| Q1 2024 | -74.02% |
| Q4 2023 | 25.74% |
| Q3 2023 | -89.58% |
| Q2 2023 | 45.65% |
| Q1 2023 | -11.56% |
| Q4 2022 | -11.92% |
| Q3 2022 | -2.30% |
| Q2 2022 | -0.92% |
| Q1 2022 | -1.33% |
| Q4 2021 | -42.91% |
| Q3 2021 | 9.16% |
| Q2 2021 | -181.11% |
| Q1 2021 | 351.52% |
| Q4 2020 | 7.08% |
| Q3 2020 | -20.62% |
| Q2 2020 | 22.05% |
| Q1 2020 | 0.00% |